WLWT: A change in mammography standards could help save lives

A new Food and Drug Administration policy will soon require health care providers to tell women if they have dense breast tissue, a trait that can make cancer harder to detect. The move is aimed to support prevention, early detection and treatment of breast cancer.

The announcement also follows advocacy from patients, lawmakers and University of Cincinnati Cancer Center physicians that led to the passage of Ohio House Bill 371, which requires insurance companies to cover additional screenings for individuals who are at high risk for breast cancer or have dense breast tissue.

Erich J. Boomgarden, MD, assistant professor in UC's College of Medicine and a UC Health radiologist, told WLWT mammography is still the standard of care, but additional MRI or ultrasound screenings can help see through dense breast tissue.

"If you get your screening mammogram, and assuming it comes back negative, meaning there was nothing suspicious in there, we would recommend getting a supplemental screening in six months," Boomgarden said. "We do that because it's helpful for us because again, by staggering it that way, then anything that may be developing, between the screening mammogram and MRI hopefully will be detected sooner then."

Watch the WLWT report.

Featured photo at top of a 3D mammogram machine. Photo/Colleen Kelley/UC Marketing + Brand.

Related Stories

3

Yahoo, local media highlight new expanded mammography bill

June 13, 2022

University of Cincinnati professors and radiologists Ann Brown and Mary Mahoney joined patient advocate Michele Young and state legislators to celebrate the passage of House Bill 371, a bill that will require insurance companies to cover additional breast cancer screenings.